RP1 clinical trials

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

This study looks at a new treatment called RP1, by itself and with another drug called nivolumab. It's for people with certain advanced cancers like lung cancer, some skin cancers, and specific solid tumours that haven't responded well to previous treatments.